Is BCYC A Good Stock To Buy Now?
In this article we will analyze whether Bicycle Therapeutics plc (NASDAQ:BCYC) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas...
No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
---|---|---|---|---|---|
1. | Tybourne Capital Management Eashwar Krishnan | 1,957,961 | $37,299 | 0.91% | |
2. | Point72 Asset Management Steve Cohen | 1,363,151 | $25,968 | +241% | 0.13% |
3. | Samlyn Capital Robert Pohly | 418,482 | $7,972 | 0.14% | |
4. | Renaissance Technologies Jim Simons | 59,500 | $1,133 | -21% | 0% |
5. | Laurion Capital Management Benjamin A. Smith | 57,892 | $1,103 | 0.01% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$14.00 | 364,286 | Large Shareholder | 1,957,961 | 2019-05-28 | Filing | |
$14.00 | 314,286 | Large Shareholder | 1,751,437 | 2019-05-29 | Filing | |
$14.00 | 168,630 | Large Shareholder | 1,769,641 | 2019-05-28 | Filing | |
$14.00 | 571,429 | Director | 571,429 | 2019-05-27 | Filing | |
$14.00 | 7,983 | Large Shareholder | 39,637 | 2019-05-28 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$33.00 | 351 | Officer, Director | 258,900 | 2021-01-20 | Filing | |
$32.02 | 100 | Officer, Director | 259,251 | 2021-01-20 | Filing | |
$31.33 | 734 | Officer, Director | 259,351 | 2021-01-20 | Filing | |
$31.09 | 100 | Officer, Director | 260,085 | 2021-01-19 | Filing | |
$30.22 | 371 | Officer, Director | 260,185 | 2021-01-19 | Filing |
No. | Name | Shares | Value (x$1000) | % Port |
---|---|---|---|---|
1. | 1,915,274 | $36,486 | 18.48% | |
2. | 1,306,965 | $24,898 | 4.18% | |
3. | 211,444 | $4,028 | 0% | |
4. | 151,730 | $2,890 | 0% | |
5. | 31,031 | $591 | 0.01% |